Education
About Us
Working with TipRanks
Follow Us
Blueberries Medical Corp (TSE:BBM)
:BBM
BBM Stock Chart & Stats
C$0.02
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.02
C$0.00(0.00%)
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.03
Previous CloseN/A
Volume0.00
Average Volume (3M)5.76K
Market Cap
C$9.90M
Enterprise ValueC$9.89M
Total Cash (Recent Filing)C$23.81K
Total Debt (Recent Filing)C$11.02K
Price to Earnings (P/E)―
Beta-1.75
Next Earnings
Apr 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding495,090,100
10 Day Avg. Volume100
30 Day Avg. Volume5,759
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)4.78
Price to Sales (P/S)8.46
P/FCF Ratio-5.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Gross Margin (~31% TTM)A sustained gross margin near 31% indicates meaningful improvement in unit economics for cultivation and formulations. Over 2–6 months this supports variable-cost coverage, gives management margin leverage as revenue scales, and increases the realistic path to operating leverage if SG&A is controlled.
Minimal Total Debt / Low LeverageVery low leverage reduces insolvency and interest-cost risk, preserving flexibility to fund operations or capex through equity or low-cost financing. This durable balance sheet strength extends the company’s runway while it works to moderate cash burn or pursue strategic investments.
Historic Revenue Expansion (2020–2024)Material top-line expansion through 2024 demonstrates sustainable market demand and commercial execution across cultivation, formulations, and channels. A prior ability to scale revenue is a durable indicator the business model can grow given distribution and product-market fit.
Bears Say
Large Operating Losses / Widening Net LossPersistent, large operating losses and a widening net loss are structural threats to equity value and reinvestment capacity. Over months this erodes retained capital, pressures management to cut investment or raise dilutive capital, and delays sustainable profitability.
Consistently Negative Operating Cash FlowOngoing negative operating cash flow and worsening cash burn force reliance on external financing or balance-sheet draws. This raises medium-term liquidity and refinancing risk, constrains strategic flexibility, and can increase financing costs or dilution until operations generate positive cash.
Declining Equity And Negative ROEFalling equity and assets alongside sharply negative ROE signal value erosion from losses. Over a 2–6 month horizon this undermines capital resilience, limits borrowing capacity despite low nominal debt, and indicates the firm must restore profitability to halt balance-sheet deterioration.
Blueberries Medical News
BBM FAQ
What was Blueberries Medical Corp’s price range in the past 12 months?
Blueberries Medical Corp lowest stock price was <C$0.01 and its highest was C$0.03 in the past 12 months.
What is Blueberries Medical Corp’s market cap?
Blueberries Medical Corp’s market cap is C$9.90M.
When is Blueberries Medical Corp’s upcoming earnings report date?
Blueberries Medical Corp’s upcoming earnings report date is Apr 24, 2026 which is in 78 days.
How were Blueberries Medical Corp’s earnings last quarter?
Blueberries Medical Corp released its earnings results on Nov 28, 2025. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
Is Blueberries Medical Corp overvalued?
According to Wall Street analysts Blueberries Medical Corp’s price is currently Overvalued.
Does Blueberries Medical Corp pay dividends?
Blueberries Medical Corp does not currently pay dividends.
What is Blueberries Medical Corp’s EPS estimate?
Blueberries Medical Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Blueberries Medical Corp have?
Blueberries Medical Corp has 495,090,100 shares outstanding.
What happened to Blueberries Medical Corp’s price movement after its last earnings report?
Blueberries Medical Corp reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Blueberries Medical Corp?
Currently, no hedge funds are holding shares in TSE:BBM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blueberries Medical Corp
Blueberries Medical Corp. engages in the growth, cultivation, development, production, and supply of medicinal cannabis and related products in Colombia. It offers medicinal-grade cannabis oil extracts and related products. The company is headquartered in Bogotá, Colombia.
Technical Analysis
Options Prices
Currently, No data available
---